Abstract
Available evidence on multiple target organ damage (TOD) in the early phases of essential hypertension is scanty. We examined the prevalence and correlates of multiple TOD in never-treated patients with recently diagnosed hypertension. A total of 602 consecutive outpatients with grades 1 and 2 hypertension underwent the following procedures: (i) routine examination, (ii) 24-h urine collection for microalbuminuria, (iii) ambulatory blood pressure monitoring over two 24-h periods within 4 weeks, (iv) echocardiography, (v) carotid ultrasonography. TOD at cardiac, vascular and renal levels was defined according to major international hypertension guidelines. Prevalence rates of patients negative for TOD (group I) or positive for one (group II), two (group III), or three (group IV) markers of TOD were as follows: 45, 33, 17 and 5%. In group II, alterations in left ventricular structure and geometry were more frequently present than carotid atherosclerosis and microalbuminuria; a similar trend was found in group III where a close association between cardiac and vascular, but not renal, signs of TOD was observed. In multiple regression analyses the risk of having three TOD was significantly related to age [odds ratio (OR): 2.11, 95% c...Continue Reading
References
Apr 1, 1977·Circulation·R B Devereux, N Reichek
Dec 1, 1992·Circulation·M J RomanR B Devereux
Jun 1, 1992·Journal of the American College of Cardiology·A GanauJ H Laragh
May 31, 1990·The New England Journal of Medicine·D LevyW P Castelli
Dec 1, 1986·Circulation·P PignoliR Paoletti
Apr 1, 1995·Journal of the American College of Cardiology·G de SimoneJ H Laragh
Oct 30, 1998·Journal of Hypertension·A ZanchettiR Ravinetto
Jan 8, 1999·The New England Journal of Medicine·D H O'LearyS K Wolfson
May 23, 2000·American Journal of Hypertension·G VaudoE Mannarino
Mar 27, 2001·Archives of Internal Medicine·G SchillaciP Verdecchia
Oct 6, 2001·Blood·O W PressD Axworthy
Nov 2, 2001·Blood Pressure·C CuspidiA Zanchetti
Mar 5, 2002·Journal of Hypertension·Kristian WachtellHans Ibsen
Apr 17, 2002·Circulation·Arno BueckerRolf W Günther
Oct 3, 2002·Circulation·Hans L HillegeUNKNOWN Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Jul 31, 2004·Journal of Human Hypertension·C CuspidiUNKNOWN APROS Investigators
Oct 14, 2004·Journal of Hypertension·Cesare CuspidiAlberto Zanchetti
Oct 16, 2004·American Journal of Hypertension·Sante D PierdomenicoAndrea Mezzetti
Mar 19, 2005·Journal of Hypertension·Cesare CuspidiAlberto Zanchetti
Oct 14, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roland E Schmieder
Nov 11, 2005·American Journal of Hypertension·Michael H OlsenRichard B Devereux
Citations
Jul 16, 2011·BMC Family Practice·Athanasia PapazafiropoulouCharalambos Tountas
Sep 30, 2008·Blood Pressure·Cesare CuspidiGiuseppe Mancia
Jul 11, 2009·Blood Pressure·Gabriel Coll de TueroMarc Saez
Apr 11, 2012·Blood Pressure·Gabriel Coll-De-TueroJesús Gelado-Ferrero
Jul 8, 2009·Blood Pressure Monitoring·Luis García-OrtizCarlos Martínez-Salgado
Aug 22, 2012·The Journal of International Medical Research·W SuS Lu
Jun 6, 2008·Journal of Human Hypertension·C CuspidiG Mancia
Sep 21, 2018·Journal of Hypertension·Bryan WilliamsUNKNOWN Authors/Task Force Members:
Feb 14, 2019·Cardiovascular Diabetology·Andrea Maria MarescaColomba Falcone
Aug 31, 2018·European Heart Journal·Bryan WilliamsUNKNOWN ESC Scientific Document Group
Dec 15, 2020·Journal of Korean Medical Science·Jung Sun OhJin Kyung Hwang
Mar 19, 2021·British Journal of Clinical Pharmacology·Paul G HunterNeeraj Dhaun